{
  "type": "hyp",
  "text": "The ability of the CD40 cytoplasmic activator TRAF2 to bind to CD40 was confirmed by studies using anti-CD40 monoclonal antibody.\n",
  "self": {
    "NER": {
      "answers": [],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": []
      }
    },
    "NOUN": {
      "answers": [
        "The ability",
        "CD40",
        "studies",
        "anti-CD40 monoclonal antibody"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "What was confirmed by studies using anti-CD40 monoclonal antibodies?",
          "What does TRAF2 bind to?",
          "What confirmed the ability of TRAF2 to bind to CD40?",
          "What was used to confirm the ability of TRAF2 to bind to CD40?"
        ]
      }
    }
  },
  "asked": {
    "What was the main effect of TRAF2 on the ability of the protein to bind to": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.445767343044281,
        "ground_truth": {
          "the phosphorylation status": {
            "bertscore": 0.6241673827171326,
            "f1": 0
          }
        }
      }
    },
    "What effect did phosphorylation status of TRAF2 have on the ability of the protein": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.17476403713226318,
        "ground_truth": {
          "significant effects": {
            "bertscore": 0.729263961315155,
            "f1": 0
          }
        }
      }
    },
    "What did the phosphorylation status of TRAF2 have significant effects on?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.006690382957458496,
        "ground_truth": {
          "the ability": {
            "bertscore": 0.6806663274765015,
            "f1": 0
          },
          "the protein": {
            "bertscore": 0.652876079082489,
            "f1": 0
          }
        }
      }
    },
    "What protein did TRAF2 interact with?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "CD40",
        "answerability": 0.9897904992103577,
        "ground_truth": {
          "CD40": {
            "bertscore": 0.9999999403953552,
            "f1": 1.0
          }
        }
      }
    },
    "What evidenced that the CD40 cytoplasmic domain interacted preferentially with under": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.17226779460906982,
        "ground_truth": {
          "our observations": {
            "bertscore": 0.6728754043579102,
            "f1": 0
          }
        }
      }
    },
    "What interacted with TRAF2?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "CD40",
        "answerability": 0.8189690113067627,
        "ground_truth": {
          "the CD40 cytoplasmic domain": {
            "bertscore": 0.6490949392318726,
            "f1": 0.5
          }
        }
      }
    },
    "What significantly enhanced the binding of TRAF2 to CD40?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.16794031858444214,
        "ground_truth": {
          "phosphatase treatment": {
            "bertscore": 0.6326336860656738,
            "f1": 0
          }
        }
      }
    },
    "What did phosphatase treatment significantly enhance?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.0035732388496398926,
        "ground_truth": {
          "the binding": {
            "bertscore": 0.7001460790634155,
            "f1": 0
          }
        }
      }
    }
  }
}